subject who be willing and able to comply with schedule visit treatment plan laboratory test and other trial procedure subject who be willing but need assistance for self administer questionnaire may be consider acceptable but must first be discuss on a case-by-case basis with the pfizer monitor prior to any to any screening test or procedure for the study 